The high FOXM1 expression in endometrial carcinoma is closely associated with the prognosis, pathological stage, and clinical grade of endometrial carcinoma patients [35] and can thus serve as a marker of endometrial carcinoma prognosis and a candidate target for its treatment [36]. Here, FOXM1 is linked to endometrial carcinoma.